(2S,7R)-2-[(1S)-1-bromopropyl]-7-[(E,1R)-1-chlorohex-3-en-5-ynyl]-2,3,6,7-tetrahydrooxepine

Details

Top
Internal ID 1e13764a-196f-49ef-a1ac-6840f99e3dd9
Taxonomy Organic oxygen compounds > Organooxygen compounds > Ethers > Dialkyl ethers
IUPAC Name (2S,7R)-2-[(1S)-1-bromopropyl]-7-[(E,1R)-1-chlorohex-3-en-5-ynyl]-2,3,6,7-tetrahydrooxepine
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C15H20BrClO/c1-3-5-6-9-13(17)15-11-8-7-10-14(18-15)12(16)4-2/h1,5-8,12-15H,4,9-11H2,2H3/b6-5+/t12-,13+,14-,15+/m0/s1
InChI Key ZAQAXRPCNVAIRN-WHCSDBDNSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H20BrClO
Molecular Weight 331.67 g/mol
Exact Mass 330.03861 g/mol
Topological Polar Surface Area (TPSA) 9.20 Ų
XlogP 5.00
Atomic LogP (AlogP) 4.45
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,7R)-2-[(1S)-1-bromopropyl]-7-[(E,1R)-1-chlorohex-3-en-5-ynyl]-2,3,6,7-tetrahydrooxepine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9949 99.49%
Caco-2 + 0.6341 63.41%
Blood Brain Barrier + 0.9250 92.50%
Human oral bioavailability - 0.5571 55.71%
Subcellular localzation Mitochondria 0.3816 38.16%
OATP2B1 inhibitior - 0.8597 85.97%
OATP1B1 inhibitior + 0.8265 82.65%
OATP1B3 inhibitior + 0.9430 94.30%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.5670 56.70%
P-glycoprotein inhibitior - 0.8571 85.71%
P-glycoprotein substrate - 0.8645 86.45%
CYP3A4 substrate + 0.5095 50.95%
CYP2C9 substrate + 0.6077 60.77%
CYP2D6 substrate - 0.7953 79.53%
CYP3A4 inhibition - 0.9074 90.74%
CYP2C9 inhibition - 0.6262 62.62%
CYP2C19 inhibition - 0.5000 50.00%
CYP2D6 inhibition - 0.9059 90.59%
CYP1A2 inhibition + 0.5295 52.95%
CYP2C8 inhibition - 0.7466 74.66%
CYP inhibitory promiscuity + 0.5200 52.00%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) + 0.5823 58.23%
Carcinogenicity (trinary) Non-required 0.4243 42.43%
Eye corrosion - 0.5545 55.45%
Eye irritation - 0.9849 98.49%
Skin irritation + 0.5438 54.38%
Skin corrosion + 0.5316 53.16%
Ames mutagenesis - 0.5600 56.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4220 42.20%
Micronuclear - 0.8100 81.00%
Hepatotoxicity + 0.6087 60.87%
skin sensitisation + 0.6250 62.50%
Respiratory toxicity - 0.5889 58.89%
Reproductive toxicity - 0.7444 74.44%
Mitochondrial toxicity - 0.8000 80.00%
Nephrotoxicity + 0.6000 60.00%
Acute Oral Toxicity (c) III 0.5301 53.01%
Estrogen receptor binding + 0.5487 54.87%
Androgen receptor binding - 0.7257 72.57%
Thyroid receptor binding + 0.5150 51.50%
Glucocorticoid receptor binding + 0.6199 61.99%
Aromatase binding - 0.6907 69.07%
PPAR gamma - 0.4860 48.60%
Honey bee toxicity - 0.8577 85.77%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity + 0.6100 61.00%
Fish aquatic toxicity + 0.8800 88.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.04% 91.11%
CHEMBL221 P23219 Cyclooxygenase-1 91.74% 90.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.73% 96.09%
CHEMBL3401 O75469 Pregnane X receptor 89.53% 94.73%
CHEMBL230 P35354 Cyclooxygenase-2 88.90% 89.63%
CHEMBL2581 P07339 Cathepsin D 88.33% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.41% 95.56%
CHEMBL3227 P41594 Metabotropic glutamate receptor 5 86.83% 96.42%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.80% 86.33%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.48% 97.09%
CHEMBL226 P30542 Adenosine A1 receptor 81.15% 95.93%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Erigeron annuus

Cross-Links

Top
PubChem 11142143
NPASS NPC168165